Cryst Reports News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Item 2.02. Results of Operations and Financial Condition. On January 9, 2023, BioCryst Pharmaceuticals, Inc. issued a press release announcing preliminary, unaudited ORLADEYO® net revenue for. | January 9, 2023

San franciscoUnited statesBiocryst pharmaceuticals incSecurities exchangeNet revenue guidanceCryst pharmaceuticalsHealthcare conferenceCurrent reportSecurities exchange actSecurities actExchange actPreliminary full yearNet revenueProvides full yearCryst reportsClinical data